Smith Anglin Financial’s CVS Health CVS Stock Holding History

Smith Anglin Financial’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,243	Closed	-$222K	–	141
2020 Q4	$222K	Buy	+3,243	New	+$211K	0.04%	126

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Smith Anglin Financial's CVS Position: Q1 2021 in Review

Smith Anglin Financial sold out of CVS Health (CVS) in Q1 2021, closing a stake of 3,243 shares — an estimated $222K sold.

Smith Anglin Financial first reported a position in CVS in Q4 2020 and held it in 1 quarter. The position peaked at $222K in Q4 2020. 2,032 funds tracked by Wall St. Rank hold CVS as of Q1 2021.

Smith Anglin Financial reported no remaining CVS Health position as of Q1 2021 after selling out during the quarter.
Smith Anglin Financial sold 3,243 CVS Health shares in Q1 2021, an estimated $222K.
Smith Anglin Financial first reported a position in CVS Health in Q4 2020 and held it in 1 quarter.
Smith Anglin Financial's CVS Health position peaked at $222K in Q4 2020.
2,032 funds tracked by Wall St. Rank held CVS Health as of Q1 2021.

Based on Smith Anglin Financial's 13F filing for Q1 2021, filed 8 Jul 2021.